Artificial Intelligence in Diabetes Management

Artificial Intelligence (AI) is revolutionizing diabetes management by enhancing prediction, diagnosis, and personalized treatment. AI-powered apps analyze glucose data, recommend insulin doses, and track lifestyle factors. Machine learning algorithms can identify risk patterns and predict complications like diabetic retinopathy or hypoglycemia. AI also supports clinical decision-making by integrating patient data and evidence-based guidelines. Virtual assistants and chatbots improve patient engagement and education. In research, AI accelerates drug discovery and genomics analysis. While challenges like data privacy and algorithm bias remain, AI has enormous potential to optimize outcomes and streamline care for individuals living with diabetes.

    Related Conference of Artificial Intelligence in Diabetes Management

    March 26-27, 2026

    7th Global summit on Diabetes and Endocrinology

    Amsterdam, Netherlands
    May 14-15, 2026

    7th World Summit on Diabetes

    Rome, Italy
    May 18-19, 2026

    57th Annual Congress on Endocrinology and Diabetes Research

    Aix-en-Provence, France
    June 22-23, 2026

    16th World Congress on Endocrinology and Diabetes

    Paris, France
    August 17-18, 2026

    4th World congress and Expo on Diabetes

    Toronto, Canada
    September 29-30, 2026

    22nd World Congress on Endocrinology & Diabetes

    Paris, France

    Artificial Intelligence in Diabetes Management Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in